التفاصيل البيبلوغرافية
| العنوان: |
Avioq Receives FDA Approval for HTLV-I/II Microelisa System. |
| المصدر: |
Biomedical Market Newsletter; 3/28/2012, Vol. 21, p1-3, 3p |
| مصطلحات موضوعية: |
HTLV-I, HTLV-II (Virus), IMMUNOGLOBULINS, BLOOD plasma, ORGAN donors |
| الشركة/الكيان: |
UNITED States. Food & Drug Administration, AVIOQ Inc. |
| مستخلص: |
The article reports the U.S. Food and Drug Administration approval of Avioq Inc.'s Human T-Lymphotropic Virus Type I and Type II (HTLV-I/II) Microelisa System used for qualitative detection of antibodies for HTLV-I/II in human serum or plasma. It states that the device is used for screening donors of blood and its components for anti-HTLV-I/II and for use in testing blood and plasma specimens to screen organ donors. It informs Ortho Clinical Diagnostics Inc. to have distribution rights in U.S. |
| قاعدة البيانات: |
Complementary Index |
